Glucopyranosyl Lipid A Adjuvant Significantly Enhances HIV Specific T and B Cell Responses Elicited by a DNA-MVA-Protein Vaccine Regimen

• Paul F. McKay ,

  * E-mail: p.mckay@imperial.ac.uk

  Affiliation Imperial College London, Department of Infectious Diseases, Division of Medicine, Norfolk Place, London, United Kingdom

  ⨯
• Alethea V. Cope,

  Affiliation Imperial College London, Department of Infectious Diseases, Division of Medicine, Norfolk Place, London, United Kingdom

  ⨯
• Jamie F. S. Mann,

  Affiliation Imperial College London, Department of Infectious Diseases, Division of Medicine, Norfolk Place, London, United Kingdom

  ⨯
• Sarah Joseph,

  Affiliation MRC Clinical Trials Unit, London, United Kingdom

  ⨯
• Mariano Esteban,

  Affiliation Centro Nacional de Biotecnología, CSIC, Department of Molecular and Cellular Biology, Campus Universidad Autónoma, Madrid, Spain

  ⨯
• Roger Tatoud,

  Affiliation Imperial College London, Department of Infectious Diseases, Division of Medicine, Norfolk Place, London, United Kingdom

  ⨯
• Darrick Carter,

  Affiliation Infectious Disease Research Institute, Seattle, Washington, United States of America

  ⨯
• Steven G. Reed,

  Affiliation Infectious Disease Research Institute, Seattle, Washington, United States of America

  ⨯
• Jonathan Weber,

  Affiliation Imperial College London, Department of Infectious Diseases, Division of Medicine, Norfolk Place, London, United Kingdom

  ⨯
• Robin J. Shattock

  Affiliation Imperial College London, Department of Infectious Diseases, Division of Medicine, Norfolk Place, London, United Kingdom

  ⨯